| Paige Katharine Stieneke, CRNA | |
|
Brian D. Allgood Army Community Hospital Usag-humphreys, Bldg # 3030, Unit 15245, Apo, AP 96271-5245 | |
| (315) 737-1411 | |
| Not Available |
| Full Name | Paige Katharine Stieneke |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | Brian D. Allgood Army Community Hospital Usag-humphreys, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366170995 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | CR001118 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paige Katharine Stieneke, CRNA Brian D. Allgood Army Community Hospital, Bldg #3031, Unit 15245, Apo, AP 96271-5245 Ph: () - | Paige Katharine Stieneke, CRNA Brian D. Allgood Army Community Hospital Usag-humphreys, Bldg # 3030, Unit 15245, Apo, AP 96271-5245 Ph: (315) 737-1411 |
News Archive
Alexion Pharmaceuticals, Inc. today announced presentation of data showing that the presence of Type II paroxysmal nocturnal hemoglobinuria (PNH) cells is correlated with thrombocytopenia, potentially indicating that patients with Type II cells experience ongoing platelet consumption and increased thrombosis risk.
A new study reports this finding, along with varying antibody prevalence among different groups and regions and between different age groups. In the current paper, available as a preprint on the medRxiv* server, the results of the sixth round of the REACT-2 study are reported.
Antibodies aren't the only immune cells needed to fight off COVID-19 -; T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published in Nature Medicine.
A key obstacle to early detection of type 1 diabetes - as well as to rapid assessment of the effectiveness of therapeutic intervention - has been the lack of direct, non-invasive technologies to visualize inflammation in the pancreas, an early manifestation of disease.
University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
› Verified 3 days ago
Kenneth Gore, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: Camp Humphreys, Building 3030, Apo, AP 96297 Phone: 315-737-1368 | |
Douglas Savey, CRNA, DNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 51 Mdg, Unit 2060, Apo, AP 96278 Phone: 315-784-4190 | |
Jayme Schaaf, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: Unit 15244, Apo, AP 96205 Phone: 402-340-0985 | |
Andrew P Hansen, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: Building 99, Unit 5024, Misawa Air Base, Apo, AP 96319 Phone: 315-226-6111 | |
Jason Frias, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: Unit 5071, Apo, AP 96328 Phone: 210-264-0813 | |
Jamie Ullmark, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: Psc 560 Box 62, Apo, AP 96376 Phone: 716-777-4603 |